226 related articles for article (PubMed ID: 30850596)
1. Framework nucleic acids as programmable carrier for transdermal drug delivery.
Wiraja C; Zhu Y; Lio DCS; Yeo DC; Xie M; Fang W; Li Q; Zheng M; Van Steensel M; Wang L; Fan C; Xu C
Nat Commun; 2019 Mar; 10(1):1147. PubMed ID: 30850596
[TBL] [Abstract][Full Text] [Related]
2. Dextran methacrylate hydrogel microneedles loaded with doxorubicin and trametinib for continuous transdermal administration of melanoma.
Huang S; Liu H; Huang S; Fu T; Xue W; Guo R
Carbohydr Polym; 2020 Oct; 246():116650. PubMed ID: 32747282
[TBL] [Abstract][Full Text] [Related]
3. Framework Nucleic Acids: A Paradigm Shift in Transdermal Drug Delivery.
Wiraja C; Yeo DC; Xu C
SLAS Technol; 2019 Oct; 24(5):531-532. PubMed ID: 31119968
[TBL] [Abstract][Full Text] [Related]
4. RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy
Gao J; Wang S; Dong X; Wang Z
Theranostics; 2021; 11(7):3301-3316. PubMed ID: 33537088
[No Abstract] [Full Text] [Related]
5. A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis.
Wei Z; Wang H; Xin G; Zeng Z; Li S; Ming Y; Zhang X; Xing Z; Li L; Li Y; Zhang B; Zhang J; Niu H; Huang W
Int J Nanomedicine; 2020; 15():6545-6560. PubMed ID: 32943867
[TBL] [Abstract][Full Text] [Related]
6. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
Ahmed KS; Shan X; Mao J; Qiu L; Chen J
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
[TBL] [Abstract][Full Text] [Related]
8. Distribution of Glutathione-Stabilized Gold Nanoparticles in Feline Fibrosarcomas and Their Role as a Drug Delivery System for Doxorubicin-Preclinical Studies in a Murine Model.
Zabielska-Koczywąs K; Wojtalewicz A; Użarowska E; Klejman A; Wojtkowska A; Dolka I; Wojnicki M; Sobczak K; Wójcik M; Shen H; Ferrari M; Lechowski R
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596317
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery.
Zhao QH; Zhang Y; Liu Y; Wang HL; Shen YY; Yang WJ; Wen LP
Med Oncol; 2010 Jun; 27(2):203-12. PubMed ID: 19280372
[TBL] [Abstract][Full Text] [Related]
11. Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin.
Nguyen HX; Bozorg BD; Kim Y; Wieber A; Birk G; Lubda D; Banga AK
Eur J Pharm Biopharm; 2018 Aug; 129():88-103. PubMed ID: 29800617
[TBL] [Abstract][Full Text] [Related]
12. An integrated targeting drug delivery system based on the hybridization of graphdiyne and MOFs for visualized cancer therapy.
Xue Z; Zhu M; Dong Y; Feng T; Chen Z; Feng Y; Shan Z; Xu J; Meng S
Nanoscale; 2019 Jun; 11(24):11709-11718. PubMed ID: 31180099
[TBL] [Abstract][Full Text] [Related]
13. Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response.
Saeed M; Zalba S; Seynhaeve ALB; Debets R; Ten Hagen TLM
Int J Nanomedicine; 2019; 14():2069-2089. PubMed ID: 30988609
[TBL] [Abstract][Full Text] [Related]
14. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
15. Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma.
Labala S; Mandapalli PK; Kurumaddali A; Venuganti VV
Mol Pharm; 2015 Mar; 12(3):878-88. PubMed ID: 25587849
[TBL] [Abstract][Full Text] [Related]
16. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes.
Han HD; Lee A; Hwang T; Song CK; Seong H; Hyun J; Shin BC
J Control Release; 2007 Jul; 120(3):161-8. PubMed ID: 17524514
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
[TBL] [Abstract][Full Text] [Related]
18. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
[TBL] [Abstract][Full Text] [Related]
19. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo.
Xiong XB; Huang Y; Lu WL; Zhang H; Zhang X; Zhang Q
Pharm Res; 2005 Jun; 22(6):933-9. PubMed ID: 15948037
[TBL] [Abstract][Full Text] [Related]
20. Poly(sebacic anhydride) nanocapsules as carriers: effects of preparation parameters on properties and release of doxorubicin.
Bagherifam S; Griffiths GW; Mælandsmo GM; Nyström B; Hasirci V; Hasirci N
J Microencapsul; 2015; 32(2):166-74. PubMed ID: 25323326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
